[LGND] QoQ Quarter Result on 31-Mar-2016 [#Q1]

Stock
[LGND] Ligand Pharmaceuticals Incorporated
Announcement Date
09-May-2016
Financial Year
2016
Quarter
31-Mar-2016 [#Q1]
Profit Trend
QoQ- 4.21%
YoY- 776.39%
Quarter Report
LGND's Result
LGND's Financial Summary
View:
Show?
Quarter Result
31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 CAGR
Revenue 38,185 21,619 19,521 29,648 21,192 17,701 18,418 62.23%
PBT 7,230 804 -9,644 9,571 5,826 7,284 22,292 -52.63%
Tax 10,355 160 -3,881 3,694 -515 -217,255 265 1038.79%
NP -3,125 644 -5,763 6,608 6,341 199,165 23,564 -
Tax Rate -143.22% -19.90% - -38.60% 8.84% 2,982.63% -1.19% -
Total Cost 41,310 20,975 25,284 23,040 14,851 -181,464 -5,146 -
Ratio Analysis
31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 CAGR
NP Margin -8.18 2.98 -29.52 22.29 29.92 1,125.16 127.94 -
Per Share
31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 CAGR
EPS -0.15 0.03 -0.28 0.32 0.32 10.01 1.19 -
EPS Diluted -0.15 0.03 -0.28 0.30 0.29 9.28 1.11 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.